ESC 365 - Enrollment of women heart failure trials – progress made, innovative next steps.

ESC Professional Premium Access

Enrollment of women heart failure trials – progress made, innovative next steps.

Session: The Lancet Women and Cardiovascular Disease Commission educational programs series: heart failure in women - what every clinician needs to know

Topic: Cardiovascular Disease in Women

Speaker: Professor C. Lam (Singapore, SG)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Professor Carolyn S P Lam

Duke-NUS Graduate Medical School Singapore, Singapore (Singapore)

166 presentations

57 followers

8 more presentations in this session

Welcome remarks.

Speaker: Professor C. Lam (Singapore, SG)

Access

Video

Global burden of cardiovascular disease in women: why does it matter?

Speaker: Professor M. Roffi (Geneva, CH)

Access

Slides

Video

Heart failure with reduced ejection fraction – sex-related aspects in pathophysiology, diagnosis, and pharmacological treatment.

Speaker: Professor I. Pina (Philadelphia, US)

Access

Slides

Video

New strategies for detection, prevention, and treatment of heart failure with preserved ejection fraction.

Speaker: Professor G. Rosano (London, GB)

Access

Slides

Video

Sex-related issues for device therapies in chronic heart failure: update on current evidence and new innovations in interventional HF trials.

Speaker: Professor J. Butler (Dallas, US)

Access

Slides

Video

Access the full session

The Lancet Women and Cardiovascular Disease Commission educational programs series: heart failure in women - what every clinician needs to know

Speakers: Professor C. Lam, Professor C. Lam, Professor M. Roffi, Professor I. Pina, Professor G. Rosano...

Access

Video

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources